Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19
Nadav Sarid,1,2 Shir Mann,1 Yair Herishanu,1,2 Chava Perry,1,2 Yael C Cohen,1,2 Inna Passage,1 Miriam Neaman,1,2 Noam Benyamini,1,2 Maayan Jean,1 Irit Avivi1,2 1Departments of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-05-01
|
| Series: | Patient Preference and Adherence |
| Subjects: | |
| Online Access: | https://www.dovepress.com/lower-patient-anxiety-and-unchanged-levels-of-adherence-to-hemato-onco-peer-reviewed-fulltext-article-PPA |
| _version_ | 1818733361662787584 |
|---|---|
| author | Sarid N Mann S Herishanu Y Perry C Cohen YC Passage I Neaman M Benyamini N Jean M Avivi I |
| author_facet | Sarid N Mann S Herishanu Y Perry C Cohen YC Passage I Neaman M Benyamini N Jean M Avivi I |
| author_sort | Sarid N |
| collection | DOAJ |
| description | Nadav Sarid,1,2 Shir Mann,1 Yair Herishanu,1,2 Chava Perry,1,2 Yael C Cohen,1,2 Inna Passage,1 Miriam Neaman,1,2 Noam Benyamini,1,2 Maayan Jean,1 Irit Avivi1,2 1Departments of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence: Irit AviviDepartment of Hematology, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 6423906, IsraelTel +972-3-6973576Fax +972-3-6974452Email iritavi@tlvmc.gov.ilObjective: Hemato-oncology patients are at high risk for morbidity and mortality from coronavirus disease (COVID-19). The resultant heightened anxiety among these patients may negatively affect adherence to therapy and treatment-related outcome. We aimed to assess whether the adoption of precautionary measures provided by the medical team led to a reduction in COVID-19-related anxiety and, consequently, to successful execution of treatment plans.Methods: All adult hemato-oncology patients actively treated or being followed-up at the outpatient service at Tel Aviv Sourasky Medical Center between March 25 and May 3, 2020, were invited to answer a questionnaire that focused on their anxiety and adherence to treatment following new measures to reduce risk of infection during the first COVID-19 outbreak.Results: One hundred and fifty patients (representing 24% of those being approached), average age 67 years, 52% male, and 57% undergoing antineoplastic therapy, responded to the survey. The introduction of precautionary measures resulted in a significant reduction in anxiety level in all patients, irrespective of age, sex, or treatment status. Attendance to scheduled visits in day care and outpatient clinics remained unchanged. Adherence to planned blood and imaging tests were 81% and 73%, respectively, and 93% of the patients were satisfied with their medical care. Thirty-two percent of patients used telemedicine. Satisfaction with telemedicine was highest among non-actively treated patients and those experiencing high anxiety levels.Conclusion: Reorganization of the hemato-oncology unit and provision of information to patients reduced COVID-19-related anxiety and enabled the same delivery of therapy as that prior to the pandemic.Keywords: anxiety, treatment adherence, COVID-19 |
| first_indexed | 2024-12-17T23:48:15Z |
| format | Article |
| id | doaj.art-c7aa4040c17442498c03c83b1e06dfab |
| institution | Directory Open Access Journal |
| issn | 1177-889X |
| language | English |
| last_indexed | 2024-12-17T23:48:15Z |
| publishDate | 2021-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Patient Preference and Adherence |
| spelling | doaj.art-c7aa4040c17442498c03c83b1e06dfab2022-12-21T21:28:14ZengDove Medical PressPatient Preference and Adherence1177-889X2021-05-01Volume 1594595264609Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19Sarid NMann SHerishanu YPerry CCohen YCPassage INeaman MBenyamini NJean MAvivi INadav Sarid,1,2 Shir Mann,1 Yair Herishanu,1,2 Chava Perry,1,2 Yael C Cohen,1,2 Inna Passage,1 Miriam Neaman,1,2 Noam Benyamini,1,2 Maayan Jean,1 Irit Avivi1,2 1Departments of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence: Irit AviviDepartment of Hematology, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 6423906, IsraelTel +972-3-6973576Fax +972-3-6974452Email iritavi@tlvmc.gov.ilObjective: Hemato-oncology patients are at high risk for morbidity and mortality from coronavirus disease (COVID-19). The resultant heightened anxiety among these patients may negatively affect adherence to therapy and treatment-related outcome. We aimed to assess whether the adoption of precautionary measures provided by the medical team led to a reduction in COVID-19-related anxiety and, consequently, to successful execution of treatment plans.Methods: All adult hemato-oncology patients actively treated or being followed-up at the outpatient service at Tel Aviv Sourasky Medical Center between March 25 and May 3, 2020, were invited to answer a questionnaire that focused on their anxiety and adherence to treatment following new measures to reduce risk of infection during the first COVID-19 outbreak.Results: One hundred and fifty patients (representing 24% of those being approached), average age 67 years, 52% male, and 57% undergoing antineoplastic therapy, responded to the survey. The introduction of precautionary measures resulted in a significant reduction in anxiety level in all patients, irrespective of age, sex, or treatment status. Attendance to scheduled visits in day care and outpatient clinics remained unchanged. Adherence to planned blood and imaging tests were 81% and 73%, respectively, and 93% of the patients were satisfied with their medical care. Thirty-two percent of patients used telemedicine. Satisfaction with telemedicine was highest among non-actively treated patients and those experiencing high anxiety levels.Conclusion: Reorganization of the hemato-oncology unit and provision of information to patients reduced COVID-19-related anxiety and enabled the same delivery of therapy as that prior to the pandemic.Keywords: anxiety, treatment adherence, COVID-19https://www.dovepress.com/lower-patient-anxiety-and-unchanged-levels-of-adherence-to-hemato-onco-peer-reviewed-fulltext-article-PPAanxietytreatment adherencecovid-19 |
| spellingShingle | Sarid N Mann S Herishanu Y Perry C Cohen YC Passage I Neaman M Benyamini N Jean M Avivi I Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 Patient Preference and Adherence anxiety treatment adherence covid-19 |
| title | Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 |
| title_full | Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 |
| title_fullStr | Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 |
| title_full_unstemmed | Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 |
| title_short | Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 |
| title_sort | lower patient anxiety and unchanged levels of adherence to hemato oncologic treatment in response to new measures to reduce hospital exposure risk to covid 19 |
| topic | anxiety treatment adherence covid-19 |
| url | https://www.dovepress.com/lower-patient-anxiety-and-unchanged-levels-of-adherence-to-hemato-onco-peer-reviewed-fulltext-article-PPA |
| work_keys_str_mv | AT saridn lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT manns lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT herishanuy lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT perryc lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT cohenyc lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT passagei lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT neamanm lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT benyaminin lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT jeanm lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 AT avivii lowerpatientanxietyandunchangedlevelsofadherencetohematooncologictreatmentinresponsetonewmeasurestoreducehospitalexposurerisktocovid19 |